跳至主要内容
临床试验/EUCTR2008-005432-32-GB
EUCTR2008-005432-32-GB进行中(未招募)不适用

Effects of an Angiotensin Receptor Antagonist Candesartan versus a calcium channel blocker Amlodipine on Microvascular Rarefaction, Endothelial Dysfunction and Microalbuminuria in Essential Hypertension

St. George's University of London (SGUL)0 个研究点目标入组 46 人开始时间: 2009年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with uncomplicated mild-to-moderate essential hypertension (sitting diastolic BP = 90 - <110 mmHg and/or systolic BP =140–<180 mmHg) who have not been previously treated for their high blood pressure. Patients age 18-75 years old.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Malignant or accelerated hypertension.
  • 2. Serum creatinine >180 µmol/L
  • 3. Ischaemic heart disease
  • 4. Cerebrovascular disease
  • 5. Impaired liver functions
  • 6. Diabetes mellitus
  • 7. Pregnancy or risk of pregnancy, or lactation
  • 8. History of alcoholism, drug abuse or other problems that are likely to invalidate the informed consent.
  • 9. Dark-skinned individuals (capillary microscopy can’t be performed).

研究者

发起方
St. George's University of London (SGUL)

相似试验